Results 31 to 40 of about 16,552 (150)

Focus on Silodosin: Pros and Cons of Uroselectivity

Research and Reports in Urology, 2020
Gianluigi Califano,1 Claudia Collà Ruvolo,1 Massimiliano Creta,1 Marco Capece,1 Roberto La Rocca,1 Giuseppe Celentano,1 Luigi Napolitano,1 Francesco Paolo Calace,1 Gianluca Spena,1 Francesco Trama,1 Felice Crocetto,1 Francesco Mangiapia,1 Nicola ...
Califano G, Collà Ruvolo C, Creta M, Capece M, La Rocca R, Celentano G, Napolitano L, Calace FP, Spena G, Trama F, Crocetto F, Mangiapia F, Longo N, Fusco F   +13 more
doaj  

Adrenergic alpha-2 receptor antagonists cease augmented oxidation of plasma proteins and anxiety of rats caused by chronic noise exposure

Noise and Health, 2020
Background: Noise is one of the environmental factors, which is considered as a powerful stressor for the organism. Generally, the acoustic stress affects the behavior and physiological state of humans and animals.
Ashkhen Lyova Manukyan, Artem Sergey Grigoryan, Lilit Serob Hunanyan, Hayk Ashot Harutyunyan, Mariam Varos Manukyan, Magdalina Mher Melkonyan   +5 more
doaj   +1 more source

Noradrenergic modulation of intrinsic and synaptic properties of lumbar motoneurons in the neonatal rat spinal cord

Frontiers in Neural Circuits, 2010
Although it is known that noradrenaline powerfully controls spinal motor networks, few data are available regarding the noradrenergic modulation of intrinsic and synaptic properties of neurons in motor networks.
Maylis Tartas, Maylis Tartas, France Morin, Grégory Barrière, Michel Goillandeau, Jean-Claude Lacaille, Jean-René Cazalets, Sandrine S Bertrand   +7 more
doaj   +1 more source

Association Between Alpha-1 Adrenoreceptor Antagonist Use and Cognitive Impairment: A Systematic Review [PDF]

International Neurourology Journal
Alpha-1 adrenergic receptor (α1-AR) antagonists are commonly used for management of benign prostatic hyperplasia or hypertension. Some studies have shown a potential link between α1-AR antagonist use and cognitive impairment.
Ryan Kingsley, Sara Tyree, Dhairya Jarsania, Christopher Edquist, Allyson Palmer, Dana Gerberi, Robert Wilfahrt, Sandeep Pagali   +7 more
doaj   +1 more source

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia

Clinical Interventions in Aging, 2011
Masaki Yoshida1, Junzo Kudoh2, Yukio Homma3, Kazuki Kawabe41Department of Medical Informatics, 2Department of Urology, Japan Labor Health and Welfare Organization, Kumamoto Rosai Hospital, Kumamoto, Japan; 3Department of Urology, Graduate School of ...
Yoshida M, Kudoh J, Homma Y, Kawabe K
doaj  

Tamsulosin in the treatment of urological disorders - a literature review

Journal of Education, Health and Sport
Benign prostatic hyperplasia (BPH) is one of the most common diseases in the elderly, affecting almost half of men over 50 years of age and nearly 90% of men over 80 years of age.
Błażej Kaczmarek, Adrian Kruk, Aleksandra Dorosz, Agnieszka Skoczeń, Michał Kulesza, Weronika Wawrzynów, Magdalena Maria Jakubowska, Natalia Rutecka, Martyna Miłoś, Agata Kuśnierz-Gibała   +9 more
doaj   +1 more source

Efficacy and safety of PDE5-Is and α-1 blockers for treating lower ureteric stones or LUTS: a meta-analysis of RCTs

BMC Urology, 2018
Background Lower ureteric stones and lower urinary tract symptoms are common in urology.Drug treatment is one of standard therapy,but the efficacy was controversial.Thus we aimed to investigate the efficacy and safety of monotherapy or combination ...
Xifeng Sun, Wei Guan, Haoran Liu, Kun Tang, Libin Yan, Yangjun Zhang, Jin Zeng, Zhiqiang Chen, Hua Xu, Zhangqun Ye   +9 more
doaj   +1 more source

Silodosin for the treatment of clinical benign prostatic hyperplasia: safety, efficacy, and patient acceptability

Research and Reports in Urology, 2014
Hee Ju Cho, Tag Keun Yoo Department of Urology, Eulji Hospital, Eulji University School of Medicine, Seoul, KoreaAbstract: α1-Adrenergic receptor antagonists are commonly used to treat male lower urinary tract symptoms and benign prostatic ...
Cho HJ, Yoo TK
doaj  

Role of cyclic AMP and cyclic GMP as modulators of platelet cytosolic calcium

Journal of Clinical and Preventive Cardiology, 2016
Studies from our laboratory at the University of Minnesota as well as that of others have demonstrated that agonist-mediated receptor stimulation leads to the activation of phospholipase C and formation of second messengers, diacyl glycerol and inositol ...
Gundu H.R. Rao
doaj   +1 more source

Estrogen Receptor Involvement in Noradrenergic Regulation of Ventromedial Hypothalamic Nucleus Glucoregulatory Neurotransmitter and Stimulus-Specific Glycogen Phosphorylase Enzyme Isoform Expression

ASN Neuro, 2020
Norepinephrine (NE) directly regulates ventromedial hypothalamic nucleus (VMN) glucoregulatory neurons and also controls glycogen-derived fuel provision to those cells.
A. S. M. H. Mahmood, Prabhat R. Napit, Md. Haider Ali, Karen P. Briski   +3 more
doaj   +1 more source